Medindia

X

Teleflora Renews Its Commitment to the Breast Cancer Research Foundation(R)

Monday, September 15, 2008 General News J E 4
Advertisement
LOS ANGELES, Sept. 15 Teleflora, the world's leadingfloral service offering only hand-arranged, hand-delivered floral arrangementsby local Teleflora florists, announced today that it is extending itspartnership with The Breast Cancer Research Foundation(R) (BCRF), anot-for-profit 501(c) (3) organization whose mission is to achieve preventionand a cure for breast cancer in our lifetime by providing critical funding forinnovative clinical and translational research at medical centers worldwide,and increasing public awareness about good breast health. A minimum of 85cents of each dollar donated to BCRF goes to breast cancer research grants andawareness programs. As part of this partnership, Teleflora will feature fivedifferent bouquets including: Teleflora's Polka Dots and Posies, Pink BlushBouquet, At First Blush, Teleflora's Pinking of You and Teleflora's SweetPinks Bouquet -- all of which will be marked on teleflora.com with thesignature BCRF pink ribbon. Every time a consumer purchases any one of thefive floral arrangements, Teleflora will donate 15% of the purchase price toBCRF, with a commitment of raising a minimum of $250,000.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080915/LAM505)

"Teleflora welcomes the opportunity to join forces once again to helpraise funds for BCRF as they work towards a cure for breast cancer in ourlifetime," said Shawn Weidmann, President, Teleflora. "Teleflora commits toraising awareness and helping find a cure for the disease and we are proud tohelp BCRF achieve that goal through the gift of flowers."

Teleflora's customers can select from a wide variety of floral gifts atvarious price points ranging from $39.95 to $79.95. Each arrangement is adelicate mix of fresh flowers, including pink roses that celebrate Teleflora'scollaboration with BCRF. The partnership kicks off this month, in advance ofBreast Cancer Awareness Month, which is in October and will continue throughJuly 31, 2009.

"Teleflora is a valued BCRF corporate alliance partner and we are thrilledthat Teleflora shares our commitment to finding a cure for breast cancer inour lifetime," said Robbie Finke Franklin, Director, Marketing, The BreastCancer Research Foundation

For more information on Teleflora's partnership with BCRF and how you canget involved, please visit http://www.teleflora.com/bcrf.asp or call310.966.8328.

About The Breast Cancer Research Foundation

The Breast Cancer Research Foundation(R) was founded in 1993 by Evelyn H.Lauder as an independent, not-for-profit 501(c) (3) organization dedicated tofunding innovative clinical and translational research. The Foundationsupports scientists at top universities and academic medical centers worldwideconducting the most advanced and promising breast cancer research that willlead to prevention and a cure in our lifetime. A minimum of 85 cents of eachdollar donated to the Foundation goes directly to breast cancer research andawareness programs. In October 2008, nearly $35 million will be awarded to165 scientists across the United States and in Australia, Canada, LatinAmerica, the Middle East, and throughout Europe. And for the seventhconsecutive year, BCRF received Charity Navigator's highest rating, fourstars, thus outperforming over 99% of the evaluated charities, while theAmerican Institute of Philanthropy has awarded BCRF its highest possiblerating of A+. BCRF is the only breast cancer organization in the U.S. toreceive these accolades. For more information, visit http://www.bcrfcure.orgor call 1.866.FIND.A.CURE.

About Teleflora

Teleflora is the world's leading floral service offering the best choicein floral arrangements and convenient local delivery. Headquartered in LosAngeles, California, Teleflora has approximately 20,000 member floriststhroughout the U.S. and Canada, with an additional 20,000 affiliated floristsoutside N
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Unibioscreen and Drais Pharmaceuticals Partner to ...
S
Thermage, Inc. Receives Retraction of Unsolicited ...